[1]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
郑荣寿, 孙可欣, 张思维, 曾红梅, 邹小, 陈茹, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28.
|
[3]
|
安澜, 曾红梅, 郑荣寿, 张思维, 孙可欣, 邹小农, 等. 2015年中国肝癌流行情况分析[J]. 中华肿瘤杂志, 2019, 41(10): 721-727.
|
[4]
|
Singh, G., Pratt, G., Yeo, G.W. and Moore, M.J. (2015) The Clothes Make the mRNA: Past and Present Trends in mRNP Fashion. Annual Review of Biochemistry, 84, 325-354.
https://doi.org/10.1146/annurev-biochem-080111-092106
|
[5]
|
Gerstberger, S., Hafner, M. and Tuschl, T. (2014) A Census of Human RNA-Binding Proteins. Nature Reviews Genetics, 15, 829-845. https://doi.org/10.1038/nrg3813
|
[6]
|
Maris, C., Dominguez, C. and Allain, F.H. (2005) The RNA Recognition Motif, A Plastic RNA-Binding Platform to Regulate Post-Transcriptional Gene Expression. The FEBS Journal, 272, 2118-2131.
|
[7]
|
Zhang, K., Barry, A.E., Lamm, R., Patel, K., Schafer, M. and Dang, H. (2022) The Role of RNA Binding Proteins in Hepatocellular Carcinoma. Advanced Drug Delivery Reviews, 182, Article ID: 114114.
https://doi.org/10.1016/j.addr.2022.114114
|
[8]
|
Ye, Z., Zhang, J., Yang, Y., Wei, Y., Li, L. and Wang, X. (2021) RNA-Binding Protein RBM6 Acts as a Tumor Suppressor Gene to Inhibit the Progression of Hepatocellular Carcinoma. Journal of BUON, 26, 402-408.
|
[9]
|
Santagata, S., Mendillo, M.L., Tang, Y.C., Subramanian, A., Perley, C.C., Roche, S.P., et al. (2013) Tight Coordination of Protein Translation and HSF1 Activation Supports the Anabolic Malignant State. Science, 341, Article ID: 1238303. https://doi.org/10.1126/science.1238303
|
[10]
|
Han, Z., Liu, D., Chen, L., He, Y., Tian, X., Qi, L., et al. (2021) PNO1 Regulates Autophagy and Apoptosis of Hepatocellular Carcinoma via the MAPK Signaling Pathway. Cell Death & Disease, 12, Article No. 552.
https://doi.org/10.1038/s41419-021-03837-y
|
[11]
|
Lukong, K.E. and Richard, S. (2003) Sam68, the KH Domain-Containing superSTAR. Biochimica et Biophysica Acta, 1653, 73-86. https://doi.org/10.1016/j.bbcan.2003.09.001
|
[12]
|
Zhang, T., Wan, C., Shi, W., Xu, J., Fan, H., Zhang, S., et al. (2015) The RNA-Binding Protein Sam68 Regulates Tumor Cell Viability and Hepatic Carcinogenesis by Inhibiting the Transcriptional Activity of FOXOs. Journal of Molecular Histology, 46, 485-497. https://doi.org/10.1007/s10735-015-9639-y
|
[13]
|
Wang, X., Zhao, B.S., Roundtree, I.A., Lu, Z., Han, D., Ma, H., et al. (2015) N6-Methyladenosine Modulates Messenger RNA Translation Efficiency. Cell, 161, 1388-1399. https://doi.org/10.1016/j.cell.2015.05.014
|
[14]
|
Luo, X., Cao, M., Gao, F. and He, X. (2021) YTHDF1 Promotes Hepatocellular Carcinoma Progression via Activating PI3K/AKT/mTOR Signaling Pathway and Inducing Epithelial-Mesenchymal Transition. Experimental Hematology & Oncology, 10, Article No. 35. https://doi.org/10.1186/s40164-021-00227-0
|
[15]
|
Kaneko, Y., Sakakibara, S., Imai, T., Suzuki, A., Nakamura, Y., Sawamoto, K., et al. (2000) Musashi1: An Evolutionally Conserved Marker for CNS Progenitor Cells Including Neural Stem Cells. Developmental Neuroscience, 22, 139-153. https://doi.org/10.1159/000017435
|
[16]
|
Chen, K., Gao, Q., Zhang, W., Liu, Z., Cai, J., Liu, Y., et al. (2015) Musashi1 Regulates Survival of Hepatoma Cell Lines by Activation of Wnt Signalling Pathway. Liver International, 35, 986-998.
|
[17]
|
Grandhi, M.S., Kim, A.K., Ronnekleiv-Kelly, S.M., Kamel, I.R., Ghasebeh, M.A. and Pawlik, T.M. (2016) Hepatocellular Carcinoma: From Diagnosis to Treatment. Surgical Oncology, 25, 74-85.
https://doi.org/10.1016/j.suronc.2016.03.002
|
[18]
|
伊日贵, 徐晓艳, 李时荣. 肿瘤侵袭转移机制研究进展[J]. 中华实用诊断与治疗杂志, 2014, 28(10): 937-939.
|
[19]
|
Yan, X.L., Jia, Y.L., Chen, L., Zeng, Q., Zhou, J.N., Fu, C.J., et al. (2013) Hepatocellular Carcinoma-Associated Mesenchymal Stem Cells Promote Hepatocarcinoma Progression: Role of the S100A4-miR155-SOCS1-MMP9 Axis. Hepatology, 57, 2274-2286.
|
[20]
|
Yang, M., Zhou, Y., Deng, H., Zhou, H., Cheng, S., Zhang, D., et al. (2021) Ribosomal Protein L23 Drives the Metastasis of Hepatocellular Carcinomavia Upregulating MMP9. Frontiers in Oncology, 11, Article ID: 779748.
https://doi.org/10.3389/fonc.2021.779748
|
[21]
|
Zhou, M. and Tong, X. (2015) Downregulated Poly-C Binding Protein-1 Is a Novel Predictor Associated with Poor Prognosis in Acute Myeloid Leukemia. Diagnostic Pathology, 10, Article No. 147.
https://doi.org/10.1186/s13000-015-0377-y
|
[22]
|
Huang, S., Luo, K., Jiang, L., Zhang, X.D., Lv, Y.H. and Li, R.F. (2021) PCBP1 Regulates the Transcription and alteRNAtive Splicing of Metastasis-Related Genes and Pathways in Hepatocellular Carcinoma. Scientific Reports, 11, Article No. 23356. https://doi.org/10.1038/s41598-021-02642-z
|
[23]
|
Kröhler, T., Kessler, S.M., Hosseini, K., List, M., Barghash, A., Patial, S., et al. (2019) The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular Carcinoma. Cancers, 11, Article No. 1754.
https://doi.org/10.3390/cancers11111754
|
[24]
|
Chen, J., Rajasekaran, M., Xia, H., Zhang, X., Kong, S.N., Sekar, K., et al. (2016) The Microtubule-Associated Protein PRC1 Promotes Early Recurrence of Hepatocellular Carcinoma in Association with the Wnt/β-Catenin Signalling Pathway. Gut, 65, 1522-1534. https://doi.org/10.1136/gutjnl-2015-310625
|
[25]
|
Zhao, L., Cao, J., Hu, K., Wang, P., Li, G., He, X., et al. (2019) RNA-Binding Protein RPS3 Contributes to Hepatocarcinogenesis by Post-Transcriptionally Up-Regulating SIRT1. Nucleic Acids Research, 47, 2011-2028.
https://doi.org/10.1093/nar/gky1209
|
[26]
|
Masuda, K. and Kuwano, Y. (2019) Diverse Roles of RNA-Binding Proteins in Cancer Traits and Their Implications in Gastrointestinal Cancers. WIREs RNA, 10, e1520.
|
[27]
|
Liu, Y., Yang, Y., Luo, Y., Wang, J., Lu, X., Yang, Z., et al. (2020) Prognostic Potential of PRPF3 in Hepatocellular Carcinoma. Aging, 12, 912-930. https://doi.org/10.18632/aging.102665
|
[28]
|
Jiang, W., Wu, T., Shi, X. and Xu, J. (2021) Overexpression of EWSR1 (Ewing Sarcoma Breakpoint Region 1/EWS RNA binding Protein 1) Predicts Poor Survival in Patients with Hepatocellular Carcinoma. Bioengineered, 12, 7941-7949. https://doi.org/10.1080/21655979.2021.1982844
|
[29]
|
Jeng, Y.M., Chang, C.C., Hu, F.C., Chou, H.Y., Kao, H.L., Wang, T.H., et al. (2008) RNA-Binding Protein Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Promotes Tumor Invasion and Predicts Early Recurrence and Poor Prognosis in Hepatocellular Carcinoma. Hepatology, 48, 1118-1127.
|
[30]
|
Song, Y., He, S., Ma, X., Zhang, M., Zhuang, J., Wang, G., et al. (2020) RBMX Contributes to Hepatocellular Carcinoma Progression and Sorafenib Resistance by Specifically Binding and Stabilizing BLACAT1. American Journal of Cancer Research, 10, 3644-3665. https://doi.org/10.21203/rs.3.rs-26102/v1
|
[31]
|
Zhang, Q., Zhang, Y., Guo, Y., Tang, H., Li, M. and Liu, L. (2021) A Novel Machine Learning Derived RNA-Binding Protein Gene-Based Score System Predicts Prognosis of Hepatocellular Carcinoma Patients. PeerJ, 9, e12572.
https://doi.org/10.7717/peerj.12572
|